You are using an outdated browser. Please upgrade your browser to improve your experience.
ketamine-induced biliary dilatation
Disease Summary
Associated Targets ()
Mondo Description Ketamine-induced biliary dilatation is an acquired biliary tract disease caused by the abusive consumption of ketamine, which results in the fusiform dilatation of the common bile ducts (CBD) without obstructive lesions or dilatation of the intrahepatic biliary ducts. Possible manifestations of the underlying cholangiopathy include epigastric pain and impaired liver function. Severity of CBD dilatation appears to correlate with the duration of ketamine consumption and the condition has been reported to be reversible in abstinent patients.
Download Data for ketamine-induced biliary dilatation
data still loading...
Counts of Target Development Levels for diseases known to be associated with this disease. If the disease has a valid DOID, targets known to be associated with all child diseases are aggregated. Click "Explore Associated Targets" to view more facets and details for the target list.
Description from Mondo Disease Ontology.
DataSources which have contributed target associations to this disease, and the identifiers by which the disease is referenced.
Orphanet:293807
SCTID:726613003
UMLS:C4512018
UMLS:CN227122
MONDO:0017394
High level summary of knowledge for a disease, including descriptions and datasource references.